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Abstract: Background: With the increasing availability of Smartphones and wearable 
tracking devices, it is now feasible and affordable to apply such mobile devices to delivering 
mindfulness-based stress reduction (MBSR) and intermittent fasting (IF) to lower blood 
pressure, as traditional MBSR and IF incur the burden of commuting to the intervention sites 
for the patients. Our study will develop and scientifically evaluate an MBSR app, an IF app 
and an MBSR + IF app in terms of their effectiveness for lowering blood pressure. We will 
further explore the possible interaction effect (synergistic effect) between MBSR and IF 
intervention: will improved mindfulness enhance patients’ adherence to the IF protocol? 
Methods: We will develop an MBSR app, an IF app, and an MBSR+IF app. We will then 
conduct an 8-week randomized controlled trial with a factorial design to evaluate the efficacy 
of these new apps, especially the interaction effect between MBSR and IF. Eligible 
individuals will be randomly assigned to Group 1 (MBSR app), Group 2 (IF app), Group 3 
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(MBSR + IF app) or Group 4 (usual care). Discussion: This will be the first attempt to explore 
the impact of mindfulness intervention on the adherence of a behavioral intervention. 
Nevertheless, our protocol is limited in that the effectiveness of intermittent fasting on lowering 
blood pressure has not been supported by large-sample randomized controlled trials. Thus if 
there is no significant effectiveness we cannot determine whether it is due to the intermittent 
fasting intervention itself or it is due to the limit of smartphone as a vehicle. 
Keywords: mindfulness based stress reduction; intermittent fasting; blood pressure 
reduction; smartphone 
 
1. Introduction 
Hypertension and prehypertension are a growing problem in the US with nearly 60 million people 
having a blood pressure (BP) in the prehypertensive range [1]. Pre-hypertension, though not identified 
as a disease, has far-reaching implications on cardiovascular risk [2,3]. While pharmacological 
treatments are available for pre-hypertension and hypertension, lifestyle interventions are still the 
preferred approach for BP management [4,5]. With the increasing availability of Smartphones and 
wearable tracking devices, it is now feasible and affordable to apply such mobile devices to delivering 
mindfulness-based stress reduction (MBSR) and intermittent fasting (IF) to lower blood pressure, as 
traditional MBSR and IF incur the burden of commuting to the intervention sites for the patients. 
It was estimated in 2013 that the average U.S. consumer spent around 2 h and 7 min a day inside 
mobile applications [6]. This has led to a surge in the number of applications available to download in 
both the Apple App Store and Google Play systems, respectively [7]. With the increasing prevalence of 
smartphones and their associated web-based applications, a rise in the use of this technology to deliver 
mobile health interventions has also been seen [8,9]. These technologies allow users to overcome various 
limitations to traditional interventions such as time, resources, flexibility, availability, and  
accessibility [10]. They have the potential to increase cost-effectiveness by reducing the time input from 
a therapist or other healthcare professional, increase participation in therapeutic activities outside usual 
clinical hours of operation, and reduce transportation cost associated with attending a health program 
and commuting to meetings.  
One increasingly popular field in health-based mobile applications is smartphone-based mindfulness 
apps, as a recent study has identified over 500 applications focused on the concept of mindfulness [8]. 
Mindfulness is defined as the nonjudgmental awareness of experiences in the present moment [11]. 
Many programs have been developed over the years that seek to improve the trait of mindfulness, and 
one of the most notable mindfulness intervention protocols is mindfulness-based stress reduction 
(MBSR) [12]. MBSR programs have been shown to increase this present centered awareness [13,14] 
and attention [15–17]. Qualitative analyses have had similar results with participants commenting on 
improved awareness and concentration as well as less mind wandering [18]. Additionally, MBSR has 
been shown to have positive results in populations suffering from stress, eating disorders, depression, 
obesity, and attention control [19,20]. Studies utilizing traditional MBSR methods have shown 
significant reduction in systolic (SBP) and diastolic (DBP) blood pressure, compared to the control  
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group [1,21–25]. Despite the number of mindfulness applications available and the amount of 
information supporting the use of traditional MBSR methods, less is known concerning the benefits of 
smartphone delivered MBSR interventions. 
A 2013 study by Plaza et al. determined that despite the number of smartphone based mindfulness 
applications, there was very little information supporting their usefulness [9]. Since that time a few 
studies have been performed that seem to support the use of mindfulness based mobile applications. 
Chittaro and Vianello developed an application devoted to a technique in mindfulness practice known 
as thought distancing and compared it to two separate traditional methods of practicing this technique in 
individuals with little or no meditation experience [26]. It was reported that participants achieved a 
higher level of decentering (the goal of this particular technique) while using the mobile application 
compared to the traditional methods. It was also noted that participants rated the mobile application more 
pleasant as well as less difficult to use. A randomized controlled trial (RCT) found that participants who 
accessed a mindfulness application for 10 days reported a significant increase in positive affect and 
reduction in depressive symptoms while no affect was seen in the control group [27]. It should be noted 
no significant differences were seen with regards to satisfaction of life, negative affect, and flourishing 
measures in the experimental group; however, it was suggested the short duration of the trial could be 
an explanation for this finding. An RCT harnessing a 2-week online mindfulness intervention found 
significant differences in mindfulness, depression and anxiety, and perceived stress with no difference 
reported in the control group [28]. Other studies using smartphone based mindfulness apps have provided 
similar significant differences of within-group effects on measures of stress, heartbeats-per-minute, and 
depression for participants using the intervention; however, between group effects were not  
found [29,30]. However, the effect of an MBSR mobile application on the measure of BP has not been 
evaluated by randomized controlled trials, leaving an important research gap. 
Similarly, other behavioral interventions shown to have positive effects on lowering BP in the 
traditional setting have also not been evaluated using a smartphone based application, such as 
intermittent fasting (IF). IF is a dietary approach for outcome improvement among chronic disease 
patients [31]. This regimen contains a “feast” period in which food intake is ad libitum, and a “fast” 
period when calorie intake is restricted. Many of the cardiovascular benefits of fasting were first 
recognized during times of religious fasting [32–34]. Several studies in rats have suggested IF can 
decrease BP along with other cardiovascular risk factors [5,35]. So far, many studies among humans 
have confirmed the cardiovascular benefits of various forms of fasting [36–42]. Two experiments with 
overweight and obese women have demonstrated the impact of IF on lowering blood pressure [43,44]. 
While the mechanism for BP lowering from fasting is thought to be partially due to weight loss, studies 
showing a decrease in BP without significant weight loss as well as in normal weight individuals 
suggests a more complex relationship [38,45]. Other mechanisms such as decreased sympathetic nervous 
system activity through decreased insulin secretion and increased insulin sensitivity as well as decreased 
age-related vascular changes have been proposed [46–48]. Despite the evidence of cardiovascular 
benefits such as lowering BP from IF, so far no studies have evaluated the effectiveness of a  
smartphone-based IF app. The lack of information available related to the BP lowering effect of 
smartphone-based IF and MBSR apps as well as the evidence supporting this effect in traditional 
methods necessitates research to fill in this gap. Also, the potential for an interaction effect between 
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these two interventions resulting in a greater effect on blood pressure suggests there is merit in 
combining them to test for an interaction. 
Various environmental cues affect peoples’ food intake volume, especially when the eater has not 
been mindful of what he or she has been eating [49]. Food over-estimation could come from 
environmental factors such as package size and labels, plate size, and meal size. Additionally, the person 
being in a mindless state could easily influence these cues leading to over-consumption. Mindfulness 
training thus might provide an effective way of reducing our mindless “choice” of food overconsumption 
by increasing awareness of present experiences and providing greater freedom from environmental  
cues [49]. The combination of a mindfulness intervention with an effective diet might lead to better 
compliance and greater outcomes [49] than a dietary intervention alone. This led to our hypothesis that 
the combination of IF and an MBSR program could be more effective at lowering BP in pre-hypertensive 
and hypertensive patients than either of the two interventions alone. 
The selected IF regimen is expected to contribute to the potential decrease of mindless eating by 
removing distractions [49]. The IF approach focuses on frequency of meals instead of food choice. By 
combining the heightened sense of awareness found in mindfulness training with decreasing external 
distractions through IF, we hypothesize that there will be a decrease in mindless eating. This potential 
interaction between the interventions could achieve a greater reduction in BP. Finally, MBSR has been 
suggested to be effective in promoting improved coping responses [50–52], indicating it may promote 
increased adherence to dietary restrictions. 
2. Experimental Section 
Our specific hypotheses are: 
 Hypothesis 1: The combination of MBSR and IF will have a significantly greater effect on 
lowering blood pressure than either stand-alone intervention and the control group. 
 Hypothesis 2: The interaction effect of the MBSR and IF interventions on the outcome of BP 
will be mediated by the impact of MBSR on fasting adherence. 
In Step I (six months), we will develop apps with self-administered trainings for MBSR, IF, and 
MBSR + IF. The new apps will have features to monitor the adherence to the treatment and track 
patients’ daily physical activities and energy intake. In Step II (4 months), we will conduct an 8-week 
randomized controlled trial (RCT) with a factorial design to evaluate the efficacy of these new apps, 
especially the interaction effect between the MBSR and IF. For participant recruitment, flyers will be 
distributed around the Clemson, Anderson, Seneca, and Greenville areas containing study information 
and requesting participation. Individuals will be asked to complete a screening survey to determine 
eligibility based on the inclusion-exclusion criteria described in Appendix. Individuals deemed eligible 
will then be randomly assigned to Group 1 (MBSR), Group 2 (IF), Group 3 (MBSR + IF) or  
Group 4 (usual care). Patients will be assessed for all measures at baseline. Subsequently, the primary 
outcome (BP) and secondary outcomes will be measured bi-weekly and post-intervention. 
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2.1. Study Population 
The study population will include 1428 men and women aged 25–50 years, diagnosed as having 
prehypertension (SBP of 120–139 mm Hg or DBP of 80–89 mm Hg) or stage-1 hypertension  
(SBP 140–159 mm Hg or DBP 90–99 mm Hg), and not taking antihypertension medications. Sample 
size was calculated using a power of 0.8 and a α of 0.05 in the STATA package of sampsi. The effect 
size of systolic blood pressure outcome was reported by Palta et al [24], as systolic blood pressure is the 
essential outcome measure of our study. According to the power analysis, 357 participants will be 
randomized into each of the four groups as described above, meaning that we will recruit a total of  
1428 patients. 
2.2. Smartphone-based Applications 
The MBSR application created will be adapted from Kabat-Zinn’s MBSR program [12]. The 
application will be designed as an 8-week intervention with weekly instruction lasting 2.5 h. The 
application will have pre-recorded meditation guides that teach participants mindfulness techniques: 
body scan, sitting meditation, and yoga [1]. The sitting meditation guides will allow participants access 
to techniques such as mindful breathing and thought distancing; Participation in these practices for at 
least 45 min a day for six days a week will be included in the app. Additionally, the application will 
assign homework such as logging of daily practice.  
An adherence feature will also be developed for the apps that provide study developers information 
on the number of times the application has been used as well as the length of time spent in the application 
doing guided meditation. Thus we obtain real-time data about the usage of these apps, one potential new 
metric of adherence in the age of eHealth. For each week these apps will ask the smartphone user a 
question about their adherence to the assigned intervention during the past week, and the users’ response 
will also become our measure of adherence.  
The created IF application will provide participants with a schedule to follow based on an IF  
regimen [38]. This will consist of a fast day on which food intake is restricted and a feast day on which 
food is consumed ad libitum. On fasting days participants will be taught to have high water intake and 
allowed to consume energy-free beverages, tea, coffee, and sugar-free gum.  
2.3. Control Group 
The control group will be given information about the dietary approaches to stop hypertension 
(DASH) dietary regimen [53], which is a recommended dietary approach to achieve desired BP [53]. 
Brochures about DASH will be given to all participants.  
2.4. Outcomes 
As for criteria for success, the following measures will be collected during the study. While BP 
improvement is considered the primary signal for the intervention success, improvement in other 
measures will signal success for our intervention as well.  
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2.4.1. Blood Pressure 
BP will be taken in a noise-free environment while the patient’s arm is supported at heart level and 
both feet on the floor [1]. The measurement will be taken three times using a blood pressure cuff with  
5 min between readings. The average of the three readings will be used as the recorded measurement. 
2.4.2. Mindfulness 
Mindfulness will be measured using the five-facet mindfulness questionnaire (FFMQ) [54]. This is a 
self-report tool consisting of 39 items focused on changes in the tendency of participants to be mindful 
in their daily lives. Questions are answered using a 5-point Likert scale with responses ranging from  
1-never or very rarely true to 5-very often or always true. This scale has been used in a similar study 
focused on technological delivery of an adapted MBSR program [28]. 
2.4.3. Fasting Adherence 
Adherence to the IF regimen will be monitored using a 24-h food recall. Participants will be asked to 
detail their food intake from the previous day and any fast day when a participant consumes food 
considered non-compliant. 
2.4.4. Stress 
Stress will be evaluated using the 10-item perceived stress scale (PSS) developed by Cohen and 
Williamson (1988) [55]. This tool is used to measure how stressful an individual perceives their life with 
questions focused on how uncontrollable, overloaded, or unpredictable they view it. Responses are based 
on a 4-point Likert scale ranging from 0-never to 4-very often. 
2.4.5. Sleep Duration 
Sleep duration per day will be collected using the wristband FitBit [56]. 
2.4.6. Anthropometric Measures 
Weight (kg), height (m), and waist circumference (cm) will also be measured at each visit. Weight 
will be measured to the nearest 0.25 kg using a balance beam scale with the participant having on no 
shoes and light clothing. Height will be measured to the nearest tenth of a meter using the height bar on 
the balance-beam scale. Waist circumference will be measured using a standard tape measure and 
placing it between the top of the participants’ hipbone and the bottom of their ribs while the breath is 
out. Measurements will be rounded to the nearest tenth of a centimeter. 
2.4.7. Physical Activity 
Frequency and duration of walking, other moderate-intense activities, and vigorous-intense activities 
will be measured by the wristband Fitbit. 
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2.5. Analysis 
We will use a mixed model analysis [57] to evaluate the effectiveness of our interventions to 
determine if our interventions prove effective in improving the above-mentioned outcome measures.  
A difference-of-difference approach will be used when every individual is set up as the fixed effect. 
Within this difference-of-difference framework, the interaction effect will be tested using the  
least-square mean function of SAS Proc Mixed procedure [58].  
3. Results and Discussion 
With the continued prevalence of prehypertension and hypertension in the US population, effective 
treatment methods are needed to counteract this growing problem. Additionally, the enormous cost, both 
direct and indirect, associated with this condition represent a barrier to effective management of BP [59]. 
This presents an opportunity for effective, low-cost interventions to play a role in ameliorating this issue. 
Due to decreased contact with healthcare professionals, increased participation in therapeutic activities 
outside the typical clinical setting, and reduced costs associated with attending a health program and 
commuting to meetings, healthcare interventions delivered by mobile devices represents a new avenue 
for patients. 
The proposed study will lead to the development of novel applications for smartphones that aid in 
self-management of BP. This research takes advantage of the low-cost and convenient nature of mobile 
health interventions, thus having the potential to reach those who find it difficult to come to a health 
center regularly. In addition, the low-cost interventions should help reduce hypertension-related cost in 
the health care system. 
Our proposed study is innovative in that it tests the effectiveness of two separate smartphone-based 
interventions, MBSR and IF, on the outcome of BP as well as other measures such as stress and 
mindfulness. The results will also provide information about the possible interaction effect of IF and 
MBSR applications on BP. Finally, the study is also innovative in that it test the effectiveness of the 
MBSR application in increasing adherence of the IF application. 
4. Conclusions 
The increased prevalence of smartphone use has provided unique opportunities to harness this 
technology to deliver mobile health interventions. This protocol will test the ability of mobile health 
interventions to deliver interventions aimed at decreasing prehypertension and hypertension. Results 
from this study will provide an early foundation for combining MBSR and IF interventions and the 
potential efficacy of this combinatorial method for decreasing BP. Additional research will be needed to 
build off these findings and to continue to seek low-cost ways of delivering interventions to manage 
blood pressure. 
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Appendix 
Inclusion and Exclusion Criteria 
Inclusion Criteria 
Patients diagnosed as having prehypertension or stage-1 hypertension. 
Consented to participation in trial. 
Age: 25–50 years. 
Exclusion Criteria 
SBP above 159 mm Hg. 
DBP above 99 mm Hg. 
Severe Hypercholesterolemia (total cholesterol >8 mmol/L)—A condition 
characterized by elevated serum cholesterol levels. 
Previous experience with meditation practices—Any previous history of yoga 
and/or meditation classes or instruction. 
Pregnancy and Nursing—Currently pregnant or breast-feeding. 
Liver Disease—Any previous diagnosis of hepatitis, cirrhosis, alcoholic liver 
disease, or other condition leading to liver dysfunction. 
Kidney Disease—Any condition resulting in kidney damage or decreased 
kidney function for over 3 months. 
Blood pressure lowering medication—Any medication prescribed by a 
physician for the purpose of directly lowering blood pressure. 
Eating disorder—A diagnosis of bulimia, anorexia, or binge eating disorder 
Cachexia/malnutrition or BMI <20—A condition leading to loss of weight, 
weakness, muscle atrophy, and loss of appetite. 
Uncontrolled Hyperthyroidism—Diagnosed overactive thyroid without 
controlled management of thyroid hormone levels. 
Poor mental health or dementia—Diagnosed as having Alzheimer’s Disease, 
Huntington’s, Schizophrenia or other cause for cognitive impairment or major 
psychiatric disorder. 
Porphyria—The heme molecule of hemoglobin functions incorrectly. 
Hypoglycemia—Blood sugar (glucose) is abnormally low. 
Diabetes Mellitus—Any history or current diagnosis whether diet controlled or 
on oral agents or on insulin. 
Illiteracy or not able not able to speak or read English language 
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